IMCR
Immunocore Holdings plc · Healthcare
Insiders sold $5.6M net in the last 90 days ·4 sellers, 0 buyers· 6 of 10 sales under Rule 10b5-1 plans· latest Form 4 filed Feb 19, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.6M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Feb 19, 2026
GOLL JOHN
Immunocore Holdings plc (IMCR) has 7 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Feb 19, 2026.
Inside the rolling window, 4 insiders at Immunocore Holdings plc reported no open-market purchases and 10 open-market sales totaling $5.6M. The most active filer is HEAD OF R&D Berman David M with 7 filings. Insiders have net sold $5.6M over the trailing 6 months. The most recent open-market filing is a sale of 698 shares by SVP, FINANCE & CAO GOLL JOHN, dated Feb 18, 2026, worth $23K.
- Industry:Biotechnology
- CEO:Bahija Jallal
- Employees:524
- HQ:Abingdon, OX, GB
- IPO:2021-02-05
| Source | |||||||
|---|---|---|---|---|---|---|---|
GOLL JOHNFirst filing | SVP, FINANCE & CAO | Sale | 698 | $23K | Feb 19 | — | SEC ↗ |
Jallal BahijaFirst filing | CHIEF EXECUTIVE OFFICER | Sale | 11,474 | $371K | Feb 19 | — | SEC ↗ |
St Leger Tina AmberFirst filing | CHIEF HR OFFICER | Sale | 1,000 | $32K | Feb 19 | — | SEC ↗ |
| HEAD OF R&D | Sale | 5,965 | $193K | Feb 19 | — | SEC ↗ | |
| HEAD OF R&D | Sale | 31,341 | $1.3M | Dec 8 | — | SEC ↗ | |
| HEAD OF R&D | Sale | 572 | $23K | Dec 8 | — | SEC ↗ | |
| HEAD OF R&D | Sale | 69,404 | $2.8M | Dec 1 | — | SEC ↗ | |
| HEAD OF R&D | Sale | 5,521 | $221K | Dec 1 | — | SEC ↗ | |
Berman David MFirst filing | HEAD OF R&D | Sale | 100 | $4K | Nov 26 | — | SEC ↗ |
Berman David MFirst filing | HEAD OF R&D | Sale | 18,020 | $721K | Nov 26 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does IMCR have?
Immunocore Holdings plc (IMCR) has 7 SEC Form 4 filings (20 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Feb 19, 2026.
When was the most recent SEC Form 4 filing for IMCR?
The most recent Form 4 filing for IMCR on Tracefour is dated Feb 19, 2026.
Who is the most active insider at IMCR?
The most active SEC Form 4 filer at IMCR in the rolling window is HEAD OF R&D Berman David M, with 7 filings.
What is the net insider flow at IMCR over the last 6 months?
Over the trailing 180 days, insiders at IMCR have net sold $5.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at IMCR in the current window?
Inside the rolling window, insiders at IMCR bought $0 and sold $5.6M based on SEC Form 4 filings.
Can I get alerts for IMCR insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Immunocore Holdings plc (IMCR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Immunocore Holdings plc is in the Healthcare sector.